
Simulations Plus Investor Relations Material
Latest events

Q2 2025
Simulations Plus
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Simulations Plus Inc
Access all reports
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. Through an extensive network of consultants, SPI provides insight in addition to the science of molecular modeling services and expert testimony in litigation relating to molecular property analysis, from both a scientific and business perspective. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
Key slides for Simulations Plus Inc


Q1 2025
Simulations Plus Inc


Q2 2025
Simulations Plus Inc
Latest articles
)
Airbnb: The Hospitality Giant Without Property
Airbnb has grown from an idea to help the Co-Founders make rent, to one of the most dominant companies in the global hospitality industry.
13 Jun 2025
)
MSCI: Indexing the World
The story of how MSCI has become the backbone of global finance through its indexes, powering decision-making across trillions in assets.
30 May 2025
)
A Purpose-Built AI Chat for Finance and IR Professionals
Quartr Pro's new AI chat lets IR and finance professionals ask anything across 13,000+ public companies and get instant answers.
27 May 2025
Ticker symbol
SLP
Country
🇺🇸 United States